Xiaodong Ren

From Structure Modification to Drug Launch: A Systematic Review of the Ongoing Development of Cyclin-Dependent Kinase Inhibitors for Multiple Cancer Therapy.

T. Qiang, Chengyuan Liang, Lei Tian, 2022, Journal of medicinal chemistry.

Development of vericiguat: The first soluble guanylate cyclase (sGC) stimulator launched for heart failure with reduced ejection fraction (HFrEF).

Jifang Liu, Chengyuan Liang, Lei Tian, 2022, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

Syringa microphylla Diels: A comprehensive review of its phytochemical, pharmacological, pharmacokinetic, and toxicological characteristics and an investigation into its potential health benefits.

Chengyuan Liang, Lei Tian, Jingyi Li, 2021, Phytomedicine : international journal of phytotherapy and phytopharmacology.

Targeting Enhancer of Zeste Homolog 2 for the Treatment of Hematological Malignancies and Solid Tumors: Candidate Structure-Activity Relationships Insights and Evolution Prospects.

Chengyuan Liang, Lei Tian, Jingyi Li, 2022, Journal of medicinal chemistry.

The development of Bruton's tyrosine kinase (BTK) inhibitors from 2012 to 2017: A mini-review.

Suresh Thareja, Chengyuan Liang, Minhang Xin, 2018, European journal of medicinal chemistry.

A Comprehensive Overview of the Antibiotics Approved in the Last Two Decades: Retrospects and Prospects

Jie Zhang, Jie Zhang, Min Li, 2023, Molecules.

RNA-dependent RNA polymerase (RdRp) inhibitors: The current landscape and repurposing for the COVID-19 pandemic

Jiayun Zhang, T. Qiang, Chengyuan Liang, 2021, European Journal of Medicinal Chemistry.

Insights into forsythia honeysuckle (Lianhuaqingwen) capsules: A Chinese herbal medicine repurposed for COVID-19 pandemic

Pengcheng Yu, Chengyuan Liang, Juan Li, 2021, Phytomedicine Plus.

Overview of all-trans-retinoic acid (ATRA) and its analogues: Structures, activities, and mechanisms in acute promyelocytic leukaemia.

Qianqian Zhao, Chengyuan Liang, Juan Li, 2021, European journal of medicinal chemistry.

The development of Coronavirus 3C-Like protease (3CLpro) inhibitors from 2010 to 2020

Qianqian Zhao, Yanlin Jian, Chengyuan Liang, 2020, European Journal of Medicinal Chemistry.